go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Alaska rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $616,595 · 10th–90th $562,341$1,412,5380%20%40%10th90th$616,595Professionalmedian $562,341 · 10th–90th $562,341$1,047,1290%50%90th$562,341$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$3,630,780.55
Median
$3,630,780.55
Typical High
$3,630,780.55
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$1,047,128.55
Moda Health
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$616,595.00
Typical High
$1,412,537.54
Moda Health
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$691,830.97
Typical High
$1,412,537.54
Premera BCBS
Setting
Facility
Modifier
Global
Typical Low
$812,830.52
Median
$891,250.94
Typical High
$1,412,537.54
Premera BCBS
Setting
Professional
Modifier
Global
Typical Low
$630,957.34
Median
$758,577.58
Typical High
$758,577.58
Providence
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$616,595.00
Typical High
$1,047,128.55
Providence
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$645,654.23
Typical High
$707,945.78
United
Setting
Professional
Modifier
Global
Typical Low
$758,577.58
Median
$851,138.04
Typical High
$954,992.59